Get the Stockscreener App
97.04
1.41%
-1.39
After Hours:
97.04
Lantheus Holdings Inc stock is traded at $97.04, with a volume of 678.29K.
It is down -1.41% in the last 24 hours and up +6.07% over the past month.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
See More
Previous Close:
$98.43
Open:
$99.09
24h Volume:
678.29K
Relative Volume:
0.80
Market Cap:
$6.66B
Revenue:
$1.50B
Net Income/Loss:
$427.61M
P/E Ratio:
16.15
EPS:
6.01
Net Cash Flow:
$423.98M
1W Performance:
-1.83%
1M Performance:
+6.07%
6M Performance:
-9.61%
1Y Performance:
+60.50%
1-Day Range:
$97.00
$100.06
1-Week Range:
$94.80
$100.73
52-Week Range:
$58.16
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Name
Lantheus Holdings Inc
Sector
Phone
978 671-8001
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
97.04 | 6.66B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
165.02 | 73.07B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.14 | 47.43B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.12 | 45.72B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.49 | 17.75B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.75 | 14.03B | 612.78M | -86.37M | -62.91M | -0.87 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Goldman | Buy |
| Sep-03-24 | Initiated | Redburn Atlantic | Buy |
| Jul-10-24 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-18-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-04-23 | Initiated | TD Cowen | Outperform |
| Sep-29-23 | Initiated | William Blair | Outperform |
| Mar-08-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-30-22 | Initiated | SVB Leerink | Outperform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| May-09-22 | Initiated | B. Riley Securities | Buy |
| Apr-13-22 | Initiated | Truist | Buy |
| Feb-01-21 | Initiated | SVB Leerink | Outperform |
| Jun-29-20 | Resumed | Jefferies | Buy |
| Aug-16-19 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Nov-02-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-08-16 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-23-16 | Resumed | Credit Suisse | Neutral |
| Feb-24-16 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-11-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| Sep-30-15 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-20-15 | Initiated | Credit Suisse | Outperform |
| Jul-20-15 | Initiated | Jefferies | Buy |
| Jul-20-15 | Initiated | RBC Capital Mkts | Outperform |
| Jul-20-15 | Initiated | Robert W. Baird | Outperform |
| Jul-20-15 | Initiated | Wells Fargo | Outperform |
View All
Lantheus Holdings Inc Stock (LNTH) Latest News
CytoSite Bio Announces Agreement with Lantheus for Granzyme B Targeted PET Imaging Radiotracer for Immunotherapy Assessment - Yahoo Finance
Returns On Capital Are A Standout For Lantheus Holdings (NASDAQ:LNTH) - Yahoo Finance
Lantheus Holdings: One Blockbuster, Evolving Pipeline (NASDAQ:LNTH) - Seeking Alpha
Are Strong Financial Prospects The Force That Is Driving The Momentum In Lantheus Holdings, Inc.'s NASDAQ:LNTH) Stock? - Simply Wall St
How to Take Advantage of moves in (LNTH) - Stock Traders Daily
Insider Sell: Marshall Robert J. Jr. Sells 10,000 Shares of Lant - GuruFocus.com
Lantheus price target lowered to $122 from $127 at B. Riley - TipRanks
B. Riley Cuts Price Target on Lantheus Holdings to $122 From $127, Keeps Buy Rating - Marketscreener.com
Lantheus Holdings CFO Marshall sells $1.01 million in stock By Investing.com - Investing.com Australia
Lantheus Holdings CFO Marshall sells $1.01 million in stock - Investing.com
Commit To Buy Lantheus Holdings At $75, Earn 14.4% Using Options - Nasdaq
Is Lantheus Holdings, Inc. (LNTH) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey
Jones Financial Companies Lllp Acquires 1,182 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Lantheus Holdings’ SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa
10 Best Healthcare Stocks For Long-Term Investment - Insider Monkey
Lantheus Holdings’ SWOT analysis: stock poised for growth amid challenges - Investing.com India
Charles Schwab Investment Management Inc. Reduces Holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Lantheus at Leerink Global Healthcare Conference: Strategic Growth Plans By Investing.com - Investing.com South Africa
Lantheus at Leerink Global Healthcare Conference: Strategic Growth Plans - Investing.com
Earnings To Watch: Lantheus Holdings Inc (LNTH) Reports Q4 2024 Result - GuruFocus.com
Trading (LNTH) With Integrated Risk Controls - Stock Traders Daily
Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - Yahoo Finance
Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives $132.86 Consensus Price Target from Analysts - Defense World
Lantheus Holdings president Paul Blanchfield sells $204,232 in stock - Investing.com Australia
Lantheus Holdings president Paul Blanchfield sells $204,232 in stock By Investing.com - Investing.com UK
Lantheus Holdings: Pylarify Makes Bull Case Despite Looming Patent Expiry (LNTH) - Seeking Alpha
Why Lantheus Holdings Stock Got Thrashed on Tuesday - AOL
Lantheus at TD Cowen Conference: Strategic Growth in Radiopharmaceuticals By Investing.com - Investing.com Canada
Lantheus at TD Cowen Conference: Strategic Growth in Radiopharmaceuticals - Investing.com
Lantheus Holdings director sells $5 million in stock - Investing.com
Lantheus Holdings' (NASDAQ:LNTH) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
IFP Advisors Inc Sells 9,598 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Why Lantheus Shares Are Facing a Downturn - TipRanks
Lantheus Holdings (NasdaqGM:LNTH) Sees 19% Surge Following 2024 Earnings US$1.534 Billion Sales Increase - Yahoo Finance
Truist Financial Corp Decreases Stock Holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Root And ZoomInfo Are Among Top 8 Mid-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio? - Benzinga
Investor Network: Lantheus Holdings Inc. to Host Earnings Call - ACCESS Newswire
Principal Securities Inc. Lowers Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
LNTH: 2025 Guidance Provided - Yahoo Finance
Decoding Lantheus Holdings Inc (LNTH): A Strategic SWOT Insight - GuruFocus.com
Lantheus Holdings Inc. Reports Strong Growth and Strategic Moves - MSN
Lantheus Holdings (LNTH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Rising Expenses - HPBL
Lantheus Holdings (NasdaqGM:LNTH) Reports 2024 Earnings Net Income Drops Despite US$1.5 Billion Revenue - Simply Wall St
Lantheus' Pylarify Hit $1B in 2024 Sales - The Motley Fool
Lantheus' Pylarify Hit $1B in 2024 Sales - Nasdaq
Truist Adjusts Price Target on Lantheus Holdings to $127 From $120, Maintains Buy Rating - Marketscreener.com
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q4 2024 Earnings Call Transcript - Insider Monkey
Mizuho cuts Lantheus stock target to $140, maintains Outperform By Investing.com - Investing.com South Africa
Mizuho cuts Lantheus stock target to $140, maintains Outperform - Investing.com
Lantheus Holdings Inc earnings beat by $0.04, revenue topped estimates - Investing.com South Africa
Lantheus (LNTH) Shares Skyrocket, What You Need To Know - The Globe and Mail
Lantheus Holdings Inc Stock (LNTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
2.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):